Lung Impedetiometric Modification in SBT and Extubation Failure
CPAP2-EIT
Electrical Impedance Tomography During Spontaneous Breathing Trial and Extubation Failure in Critically Ill Patients: an Observational Study
1 other identifier
observational
80
0 countries
N/A
Brief Summary
Weaning is the entire process aimed at liberating patients from mechanical ventilation and endotracheal intubation. Weaning should be considered as early as possible in order to reduce the time spent in invasive mechanical ventilation (iMV), which is associated with morbidity and mortality. To verify if patients are ready to be extubated, a spontaneous breathing trial (SBT) is performed. At this stage some clinical indices and objective parameters are evaluated, such as the breathing pattern, gas exchange, haemodynamic stability and patient's comfort. In case of SBT success, the patient can be extubated. However, a post-extubation respiratory failure can occur within the first 48 hours after extubation, thus making extubation unsuccessful. Some patients considered at risk for post-extubation respiratory failure benefit from the application of non-invasive ventilation (NIV) after extubation. Early characterization of these patients is crucial to improve their clinical outcomes. Electrical Impedance Tomography (EIT) has been introduced in clinical practice as a non-invasive bedside monitoring tool to evaluate the aeration and ventilation of different lung regions. EIT has been proposed to guide ventilator settings adjustments in critically ill patients and to monitor prolonged weaning. However, the potential of EIT to assess SBT and after extubation in a general ICU population has never been evaluated insofar. The present study aims to describe the modifications of lung aeration, ventilation and inhomogeneity occurring during SBT and after extubation in a general population of critically ill patients at the first SBT attempt.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 27, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2016
CompletedFirst Submitted
Initial submission to the registry
February 10, 2019
CompletedFirst Posted
Study publicly available on registry
March 28, 2019
CompletedMarch 29, 2019
March 1, 2019
1.1 years
February 10, 2019
March 27, 2019
Conditions
Outcome Measures
Primary Outcomes (13)
Change of end-expiratory lung impedance (dEELI) from baseline at first 5 minute of Spontaneous Breathing Trial (SBT_0)
change from baseline, expressed in mL, of the end expiratory lung volume as assessed through electrical impedance tomography
At 5 minutes of Spontaneous Breathing Trial (SBT)
Change of end-expiratory lung impedance (dEELI) from baseline at last 5 minute of Spontaneous Breathing Trial (SBT_30)
change from baseline, expressed in mL, of the end expiratory lung volume as assessed through electrical impedance tomography
At the last 5 minutes of Spontaneous Breathing Trial (SBT)
Change of end-expiratory lung impedance (dEELI) from baseline at first 5 minute after extubation (SB_0)
change from baseline, expressed in mL, of the end expiratory lung volume as assessed through electrical impedance tomography
At 5 minutes after extubation
Change of end-expiratory lung impedance (dEELI) from baseline at last 30 minute after extubation (SB_30)
change from baseline, expressed in mL, of the end expiratory lung volume as assessed through electrical impedance tomography
At 30 minutes after extubation
Change of tidal volume in percentage (dVt%) from baseline at last 5 minute of SBT (SBT_0)
change from baseline, expressed in percentage, of the end expiratory lung volume as assessed through electrical impedance tomography
At 5 minutes of spontaneous breathing trial (SBT_0)
Change of tidal volume in percentage (dVt%) from baseline from baseline at 30 minute of Spontaneous Breathing Trial (SBT_30)
change from baseline, expressed in percentage, of the end expiratory lung volume as assessed through electrical impedance tomography
At the last 5 minutes of Spontaneous Breathing Trial (SBT) (SBT_30)
Change of tidal volume in percentage (dVt%) from baseline after 5 minutes from extubation (SB_0)
change from baseline, expressed in percentage, of the end expiratory lung volume as assessed through electrical impedance tomography
At 5 minutes after extubation (SB_0)
Change of tidal volume in percentage (dVt%) from baseline at last 30 minute after extubation (SB_30)
change from baseline, expressed in percentage, of the end expiratory lung volume as assessed through electrical impedance tomography
At 30 minutes after extubation (SB_30)
Inhomogeneity Index (GI) at baseline
Inhomogeneity Index (GI) as assessed through electrical impedance tomography
At baseline during Pressure Support Ventilation
Inhomogeneity Index (GI) after 5 minutes of the Spontaneous Breathing Trials (SBT_0)
Inhomogeneity Index (GI) as assessed through electrical impedance tomography
At 5 minutes of Spontaneous Breathing Trial (SBT_0)
Inhomogeneity Index (GI) after 30 minutes of the Spontaneous Breathing Trials (SBT_30)
Inhomogeneity Index (GI) as assessed through electrical impedance tomography
At 30 minutes of Spontaneous Breathing Trial (SBT_30)
Inhomogeneity Index (GI) after 5 minutes from extubation (SB_0)
Inhomogeneity Index (GI) as assessed through electrical impedance tomography
At 5 minutes after extubation (SB_0)
Inhomogeneity Index (GI) after 30 minutes from extubation (SB_30)
Inhomogeneity Index (GI) as assessed through electrical impedance tomography
At 30 minutes after extubation (SB_30)
Secondary Outcomes (8)
Arterial Blood Gases at baseline
At baseline during Pressure Support Ventilation
Arterial Blood Gases at SBT_30
At 30 minutes of Spontaneous Breathing Trial (SBT_30)
Arterial Blood Gases at SB_30
At 30 minutes after extubation (SB_30)
the ratio between respiratory rate (RR) and tidal volume (Vt) (RR/Vt) at baseline
At baseline during Pressure Support Ventilation
the ratio between respiratory rate (RR) and tidal volume (Vt) (RR/Vt) at 5 minutes of Spontaneous Breathing Trial (SBT_0)
At 5 minutes of Spontaneous Breathing Trial (SBT_0)
- +3 more secondary outcomes
Study Arms (4)
SBT Success
Patients took part of this cohort when succeeding the Spontaneous Breathing Trial (SBT).
SBT Failure
Patients took part of this cohort when failing the Spontaneous Breathing Trial (SBT). SBT Failure is defined by one or more of the following criteria occurring during the SBT: 1. loss of ≥ 2 points of Glasgow Coma Scale 2. respiratory rate/ tidal volume ≥105 breaths/min/L 3. arterial partial pressure of oxygen ≤60 mmHg on inspired oxygen fraction (FiO2) ≥0.5 and/or pH \<7.32 or a decrease in pH ≥0.07 units at the end of the SBT 4. systolic Blood Pressure \<90 mmHg or ≥180 mmHg or increased by ≥20% 5. Heart Rate \>140 beats/min or increased by 20% 6. onset of major heart arrhythmias, or electrocardiographic signs of cardiac ischemia 7. Respiratory Rate ≥35 breaths/min or increased by ≥50% 8. increased effort, respiratory distress (as indicated by diaphoresis, accessory respiratory muscles recruitment, facial signs of distress and/or paradoxical breath)
Extubation Success
Patients took part of this cohort when, after extubation, did not need continuous positive airways pressure (CPAP), non invasive ventilation (NIV) or reintubation within 48 hours.
Extubation Failure
Need for continuous positive airways pressure (CPAP), non invasive ventilation (NIV) or reintubation within 48 hours from extubation, as defined by: 1. Respiratory Rate \>25 breaths/min for 2 hours 2. Heart Rate \>140 beats/min or sustained increase or decrease \>20% 3. clinical signs of respiratory muscle failure 4. arterial partial pressure of oxygen (PaO2) \<80 mmHg on inspired oxygen fraction (FiO2) ≥50% 5. Arterial partial pressure of carbon dioxide \>45 mmHg with pH \<7.33
Interventions
After enrollment, a silicon EIT belt of proper size with 16 electrodes was placed around the patient's chest between the 4th and 6th intercostal spaces, and connected to the EIT device. All patients were ventilated in Pressure Support Ventilation (PSV) mode, with a dedicated ventilator connected to the EIT device. We acquired 5-min EIT data records at baseline (during PSV), during the first (SBT\_0) and the last (SBT\_30) 5 minutes of SBT, and, when the patient was extubated, during spontaneous breathing soon after (SB\_0) and 30 minutes after extubation (SB\_30). EIT and ventilator data were recorded at a sample of 20 Hz. The last 3 minutes of each record were analyzed. We measured respiratory rate (RR); Vt changes from baseline, expressed as percent (dVt%); dEELI variations from baseline, expressed in mL; the Global Inhomogeneity index (GI); Impedance ratio (IR) and the Center of Ventilation (CoV).
Eligibility Criteria
We considered eligible any critically ill patient ≥18 years receiving invasive Mechanical Ventilation for at least 48 hours through an orotracheal tube, ready for the first Spontaneous Breathing Trial attempt, and met at least one criteria for increased risk of extubation failure.
You may qualify if:
- Glasgow Coma Scale ≥8
- presence of clearly audible cough during suctioning with need for tracheal suctioning ≤2/hour
- normal sodium blood values
- core temperature \<38.5° during the previous 8 hours
- Arterial partial pressure of oxygen to inspired oxygen fraction (PaO2/FiO2) ≥200 mmHg, with a Positive End Expiratory Pressure ≤5 cmH2O and FiO2 ≤0.4
- stable cardiovascular status (i.e., HR ≤140 beats/min, sBP between 90 and 160 mmHg without need for vasopressin, epinephrine or norepinephrine infusion, or with dopamine or dobutamine infusion ≤5 mcg/kg/min)
- cuff leak volume \>110 mL
You may not qualify if:
- major heart arrhythmias or cardiac ischemia
- pneumothorax or emphysema
- recent (1 week) thoracic surgery
- presence of chest burns
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (16)
Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, Pearl R, Silverman H, Stanchina M, Vieillard-Baron A, Welte T. Weaning from mechanical ventilation. Eur Respir J. 2007 May;29(5):1033-56. doi: 10.1183/09031936.00010206.
PMID: 17470624BACKGROUNDNava S, Gregoretti C, Fanfulla F, Squadrone E, Grassi M, Carlucci A, Beltrame F, Navalesi P. Noninvasive ventilation to prevent respiratory failure after extubation in high-risk patients. Crit Care Med. 2005 Nov;33(11):2465-70. doi: 10.1097/01.ccm.0000186416.44752.72.
PMID: 16276167BACKGROUNDFerrer M, Sellares J, Valencia M, Carrillo A, Gonzalez G, Badia JR, Nicolas JM, Torres A. Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial. Lancet. 2009 Sep 26;374(9695):1082-8. doi: 10.1016/S0140-6736(09)61038-2. Epub 2009 Aug 12.
PMID: 19682735BACKGROUNDFerrer M, Valencia M, Nicolas JM, Bernadich O, Badia JR, Torres A. Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial. Am J Respir Crit Care Med. 2006 Jan 15;173(2):164-70. doi: 10.1164/rccm.200505-718OC. Epub 2005 Oct 13.
PMID: 16224108BACKGROUNDEl-Solh AA, Aquilina A, Pineda L, Dhanvantri V, Grant B, Bouquin P. Noninvasive ventilation for prevention of post-extubation respiratory failure in obese patients. Eur Respir J. 2006 Sep;28(3):588-95. doi: 10.1183/09031936.06.00150705. Epub 2006 May 31.
PMID: 16737982BACKGROUNDVianello A, Arcaro G, Braccioni F, Gallan F, Marchi MR, Chizio S, Zampieri D, Pegoraro E, Salvador V. Prevention of extubation failure in high-risk patients with neuromuscular disease. J Crit Care. 2011 Oct;26(5):517-524. doi: 10.1016/j.jcrc.2010.12.008. Epub 2011 Jan 26.
PMID: 21273033BACKGROUNDOrnico SR, Lobo SM, Sanches HS, Deberaldini M, Tofoli LT, Vidal AM, Schettino GP, Amato MB, Carvalho CR, Barbas CS. Noninvasive ventilation immediately after extubation improves weaning outcome after acute respiratory failure: a randomized controlled trial. Crit Care. 2013 Mar 4;17(2):R39. doi: 10.1186/cc12549.
PMID: 23497557BACKGROUNDMeade M, Guyatt G, Cook D, Griffith L, Sinuff T, Kergl C, Mancebo J, Esteban A, Epstein S. Predicting success in weaning from mechanical ventilation. Chest. 2001 Dec;120(6 Suppl):400S-24S. doi: 10.1378/chest.120.6_suppl.400s.
PMID: 11742961BACKGROUNDCosta EL, Lima RG, Amato MB. Electrical impedance tomography. Curr Opin Crit Care. 2009 Feb;15(1):18-24. doi: 10.1097/mcc.0b013e3283220e8c.
PMID: 19186406BACKGROUNDFrerichs I, Amato MB, van Kaam AH, Tingay DG, Zhao Z, Grychtol B, Bodenstein M, Gagnon H, Bohm SH, Teschner E, Stenqvist O, Mauri T, Torsani V, Camporota L, Schibler A, Wolf GK, Gommers D, Leonhardt S, Adler A; TREND study group. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group. Thorax. 2017 Jan;72(1):83-93. doi: 10.1136/thoraxjnl-2016-208357. Epub 2016 Sep 5.
PMID: 27596161BACKGROUNDZhao Z, Peng SY, Chang MY, Hsu YL, Frerichs I, Chang HT, Moller K. Spontaneous breathing trials after prolonged mechanical ventilation monitored by electrical impedance tomography: an observational study. Acta Anaesthesiol Scand. 2017 Oct;61(9):1166-1175. doi: 10.1111/aas.12959. Epub 2017 Aug 17.
PMID: 28832898BACKGROUNDBickenbach J, Czaplik M, Polier M, Marx G, Marx N, Dreher M. Electrical impedance tomography for predicting failure of spontaneous breathing trials in patients with prolonged weaning. Crit Care. 2017 Jul 12;21(1):177. doi: 10.1186/s13054-017-1758-2.
PMID: 28697778BACKGROUNDNavalesi P, Frigerio P, Moretti MP, Sommariva M, Vesconi S, Baiardi P, Levati A. Rate of reintubation in mechanically ventilated neurosurgical and neurologic patients: evaluation of a systematic approach to weaning and extubation. Crit Care Med. 2008 Nov;36(11):2986-92. doi: 10.1097/CCM.0b013e31818b35f2.
PMID: 18824909BACKGROUNDYang KL, Tobin MJ. A prospective study of indexes predicting the outcome of trials of weaning from mechanical ventilation. N Engl J Med. 1991 May 23;324(21):1445-50. doi: 10.1056/NEJM199105233242101.
PMID: 2023603BACKGROUNDZhao Z, Moller K, Steinmann D, Frerichs I, Guttmann J. Evaluation of an electrical impedance tomography-based Global Inhomogeneity Index for pulmonary ventilation distribution. Intensive Care Med. 2009 Nov;35(11):1900-6. doi: 10.1007/s00134-009-1589-y. Epub 2009 Aug 4.
PMID: 19652949BACKGROUNDLonghini F, Maugeri J, Andreoni C, Ronco C, Bruni A, Garofalo E, Pelaia C, Cavicchi C, Pintaudi S, Navalesi P. Electrical impedance tomography during spontaneous breathing trials and after extubation in critically ill patients at high risk for extubation failure: a multicenter observational study. Ann Intensive Care. 2019 Aug 13;9(1):88. doi: 10.1186/s13613-019-0565-0.
PMID: 31410738DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Federico Longhini
Intensive Care Unit, University Hospital Mater Domini, Department of Medical and Surgical Sciences, Magna Graecia University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 10, 2019
First Posted
March 28, 2019
Study Start
June 1, 2015
Primary Completion
June 27, 2016
Study Completion
June 30, 2016
Last Updated
March 29, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Data will be available from paper publication without any closing data
The full protocol, datasets used and analysed during the current study are available on reasonable request at longhini.federico@gmail.com.